Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Capital Work in Progress ₹655 Cr₹306 Cr₹207 Cr₹493 Cr₹670 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹655 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹655 Cr
Mar2025₹306 Cr
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2026 ₹655 Cr
113.89
Mar2025 ₹306 Cr
47.82
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,753.4 Cr -1.6% 0.9% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹112,205.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.9% 4% -7.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.6%

0.9%

-4.7%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses